Movement Alert|INSILICO Falls 5.52% in Regular Trading, Trading at HK$40.94

Market Focus07-30

On July 30, INSILICO fell 5.52% in regular trading, trading at HK$40.94/share, with turnover of HK$218 million.

Within the Life Sciences Tools & Services sector where INSILICO belongs, the overall sector experienced broad weakness. Among individual stocks, WUXI BIO down 6.04%, GENSCRIPT BIO down 4.94%, WUXI APPTEC down 4.29%, XTALPI down 3.68%, WUXI XDC down 6.57%.

INSILICO is a company principally engaged in AI-driven drug discovery and pipeline development. The company generates clinical or IND-stage assets through its proprietary AI platform Pharma.AI, and is also involved in software solutions and R&D services related to non-pharmaceutical fields.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment